FOLH1 and neoplasm: This is in accordance with the findings of preclinical studies showing that PSMA uptake in the tumor is directly associated with the number of tumor cells and that decreased PSMA uptake after therapy is not due to treatment-induced changes but rather reliably reflects the number of living tumor cells [23].